BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21083339)

  • 1. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs.
    Denniff P; Spooner N
    Bioanalysis; 2010 Aug; 2(8):1385-95. PubMed ID: 21083339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-cut dried blood spot (PCDBS): an alternative to dried blood spot (DBS) technique to overcome hematocrit impact.
    Youhnovski N; Bergeron A; Furtado M; Garofolo F
    Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2951-8. PubMed ID: 21913274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study to assess the effect of age of control human and animal blood on its suitability for use in quantitative bioanalytical DBS methods.
    Abu-Rabie P; Spooner N
    Bioanalysis; 2010 Aug; 2(8):1373-84. PubMed ID: 21083338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations.
    Spooner N; Ramakrishnan Y; Barfield M; Dewit O; Miller S
    Bioanalysis; 2010 Aug; 2(8):1515-22. PubMed ID: 21083351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method.
    Spooner N; Lad R; Barfield M
    Anal Chem; 2009 Feb; 81(4):1557-63. PubMed ID: 19154107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of storage conditions on the weight and appearance of dried blood spot samples on various cellulose-based substrates.
    Denniff P; Spooner N
    Bioanalysis; 2010 Nov; 2(11):1817-22. PubMed ID: 21083489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hematocrit and punch location on assay bias during quantitative bioanalysis of dried blood spot samples.
    O'Mara M; Hudson-Curtis B; Olson K; Yueh Y; Dunn J; Spooner N
    Bioanalysis; 2011 Oct; 3(20):2335-47. PubMed ID: 22011181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing DBS methodology for the determination of Compound A in monkey blood: GLP method validation and investigation of the impact of blood spreading on performance.
    Fan L; Lee J; Hall J; Tolentino EJ; Wu H; El-Shourbagy T
    Bioanalysis; 2011 Jun; 3(11):1241-52. PubMed ID: 21649500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the feasibility of using the DBS technique for metabolite radioprofiling.
    Wang L; Zeng Z; Emmons G
    Bioanalysis; 2010 Aug; 2(8):1365-71. PubMed ID: 21083337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct quantitative bioanalysis of drugs in dried blood spot samples using a thin-layer chromatography mass spectrometer interface.
    Abu-Rabie P; Spooner N
    Anal Chem; 2009 Dec; 81(24):10275-84. PubMed ID: 19919036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perforated dried blood spot accurate microsampling: the concept and its applications in toxicokinetic sample collection.
    Li F; Ploch S; Fast D; Michael S
    J Mass Spectrom; 2012 May; 47(5):655-67. PubMed ID: 22576879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dried blood spot sampling for quantitative bioanalysis: time for a revolution?
    Spooner N
    Bioanalysis; 2010 Nov; 2(11):1781. PubMed ID: 21083481
    [No Abstract]   [Full Text] [Related]  

  • 13. Human DBS sampling with LC-MS/MS for enantioselective determination of metoprolol and its metabolite O-desmethyl metoprolol.
    Liang X; Jiang H; Chen X
    Bioanalysis; 2010 Aug; 2(8):1437-48. PubMed ID: 21083344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of naproxen using DBS: evaluation & pharmacokinetic comparison of human plasma versus human blood DBS.
    Youhnovski N; Michon J; Latour S; Mess JN; Bergeron A; Furtado M; Rufiange M; Guibord P; Lefebvre M; Macarthur RB; Garofolo F
    Bioanalysis; 2010 Aug; 2(8):1501-13. PubMed ID: 21083350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules.
    Li W; Tse FL
    Biomed Chromatogr; 2010 Jan; 24(1):49-65. PubMed ID: 20017122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating and defining sample preparation procedures for DBS LC-MS/MS assays.
    Liu G; Patrone L; Snapp HM; Batog A; Valentine J; Cosma G; Tymiak A; Ji QC; Arnold ME
    Bioanalysis; 2010 Aug; 2(8):1405-14. PubMed ID: 21083341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GlaxoSmithKline's experience of incurred sample reanalysis for dried blood spot samples.
    Barfield M; Ahmad S; Busz M
    Bioanalysis; 2011 May; 3(9):1025-30. PubMed ID: 21545350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DBS: a UK (MHRA) regulatory perspective.
    Beharry M
    Bioanalysis; 2010 Aug; 2(8):1363-4. PubMed ID: 21083336
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid analysis of dried blood spot samples with sub-2-µm LC-MS/MS.
    Mather J; Rainville PD; Spooner N; Evans CA; Smith NW; Plumb RS
    Bioanalysis; 2011 Feb; 3(4):411-20. PubMed ID: 21338261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the DBS methodology to a toxicokinetic study in rats and transferability of analysis between bioanalytical laboratories.
    Turpin PE; Burnett JE; Goodwin L; Foster A; Barfield M
    Bioanalysis; 2010 Aug; 2(8):1489-99. PubMed ID: 21083349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.